Karin Jooss, EVP, Head of Research and Development at Gritstone Oncology, holds 648.85K shares in Gritstone Oncology (Ticker: GRTS), holds 9.85K shares in Fate Therapeutics (Ticker: FATE).

See the Hottest Stocks Based on Insider Trading >

Karin Jooss
Gritstone Oncology (GRTS)
EVP, Head of Research and Development

Not Ranked

Karin Jooss has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

91.46%

GRTS

8.54%

FATE

A breakdown of Karin Jooss's holdings

See the Top Stocks by Insiders

Insider Roles

Gritstone Oncology
(GRTS)

EVP, Head of Research and Development

Fate Therapeutics
(FATE)

Director

Roles that Karin Jooss holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Fate Therapeutics
(FATE)

Rating:Informative Sell

Date:Jun 06, 2022 - Jun 06, 2023

Return:+74.90%

The most profitable trade made by Karin Jooss

See the Latest Stocks Traded by Insiders

Karin Jooss's Trading History

GRTS

Gritstone Oncology

Feb 05, 2024

EVP, Head of Research and Development

Uninformative Buy

―

$478.85K

FATE

Fate Therapeutics

Jun 13, 2022

Director

Uninformative Buy

―

$44.71K

List of latest transactions for each holding click on a transaction to see Karin Jooss's performance on stock

See All Insider Trading from Today

Karin Jooss insider profile FAQ

What is the percentage of profitable transactions made by Karin Jooss?

The percentage of profitable transactions made by Karin Jooss is ―.

What is the average return per transaction made by Karin Jooss?

The average return per transaction made by Karin Jooss is ―.

What stocks does Karin Jooss hold?

Karin Jooss holds: GRTS, FATE stocks.

What was Karin Jooss’s latest transaction?

Karin Jooss latest transaction was an Uninformative Buy of ―.

What was Karin Jooss's most profitable transaction?

Karin Jooss’s most profitable transaction was an Informative Sell of FATE stock on June 6, 2022. The return on the trade was 74.90%.

What is Karin Jooss's role in Gritstone Oncology?

Karin Jooss's role in Gritstone Oncology is EVP, Head of Research and Development.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Karin Jooss Insider Profile

Karin Jooss Gritstone Oncology (GRTS)EVP, Head of Research and Development